1. Home
  2. MKTX vs PTCT Comparison

MKTX vs PTCT Comparison

Compare MKTX & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MarketAxess Holdings Inc.

MKTX

MarketAxess Holdings Inc.

HOLD

Current Price

$164.60

Market Cap

6.0B

Sector

Finance

ML Signal

HOLD

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$65.66

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MKTX
PTCT
Founded
2000
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
5.5B
IPO Year
2004
2006

Fundamental Metrics

Financial Performance
Metric
MKTX
PTCT
Price
$164.60
$65.66
Analyst Decision
Hold
Buy
Analyst Count
9
16
Target Price
$204.38
$80.94
AVG Volume (30 Days)
401.7K
976.6K
Earning Date
05-06-2026
05-05-2026
Dividend Yield
1.90%
N/A
EPS Growth
N/A
264.48
EPS
6.64
7.78
Revenue
$397,471,000.00
$264,734,000.00
Revenue This Year
$9.90
N/A
Revenue Next Year
$7.38
$19.30
P/E Ratio
$24.71
$8.50
Revenue Growth
7.45
36.19
52 Week Low
$156.17
$35.95
52 Week High
$232.84
$87.50

Technical Indicators

Market Signals
Indicator
MKTX
PTCT
Relative Strength Index (RSI) 30.32 45.34
Support Level $158.44 $61.43
Resistance Level $176.74 $69.23
Average True Range (ATR) 4.18 2.27
MACD -1.93 0.29
Stochastic Oscillator 7.36 50.65

Price Performance

Historical Comparison
MKTX
PTCT

About MKTX MarketAxess Holdings Inc.

Founded in 2000, MarketAxess is a leading electronic fixed-income trading platform that connects broker/dealers and institutional investors. The company is primarily focused on credit based fixed income securities with its main trading products being US investment-grade and high-yield bonds, Eurobonds, and Emerging Market corporate debt. Recently the company has expanded more aggressively into Treasuries and municipal bonds with the acquisitions of LiquidityEdge and MuniBrokers in 2019 and 2021, respectively. The company also provides pre- and post-trade services with its acquisition of Regulatory Reporting Hub from Deutsche Börse Group in 2020 adding to its product offerings.

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

Share on Social Networks: